1. Home
  2. GOSS vs TTEC Comparison

GOSS vs TTEC Comparison

Compare GOSS & TTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • TTEC
  • Stock Information
  • Founded
  • GOSS 2015
  • TTEC 1982
  • Country
  • GOSS United States
  • TTEC United States
  • Employees
  • GOSS N/A
  • TTEC N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • TTEC Retail: Computer Software & Peripheral Equipment
  • Sector
  • GOSS Health Care
  • TTEC Technology
  • Exchange
  • GOSS Nasdaq
  • TTEC Nasdaq
  • Market Cap
  • GOSS 203.3M
  • TTEC 178.1M
  • IPO Year
  • GOSS 2019
  • TTEC 1996
  • Fundamental
  • Price
  • GOSS $1.11
  • TTEC $5.30
  • Analyst Decision
  • GOSS Strong Buy
  • TTEC Buy
  • Analyst Count
  • GOSS 4
  • TTEC 4
  • Target Price
  • GOSS $7.50
  • TTEC $10.83
  • AVG Volume (30 Days)
  • GOSS 1.5M
  • TTEC 315.2K
  • Earning Date
  • GOSS 05-20-2025
  • TTEC 05-08-2025
  • Dividend Yield
  • GOSS N/A
  • TTEC N/A
  • EPS Growth
  • GOSS N/A
  • TTEC N/A
  • EPS
  • GOSS N/A
  • TTEC N/A
  • Revenue
  • GOSS $114,701,000.00
  • TTEC $2,165,177,000.00
  • Revenue This Year
  • GOSS N/A
  • TTEC N/A
  • Revenue Next Year
  • GOSS $172.31
  • TTEC N/A
  • P/E Ratio
  • GOSS N/A
  • TTEC N/A
  • Revenue Growth
  • GOSS N/A
  • TTEC N/A
  • 52 Week Low
  • GOSS $0.50
  • TTEC $3.11
  • 52 Week High
  • GOSS $1.55
  • TTEC $8.45
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 55.81
  • TTEC 73.36
  • Support Level
  • GOSS $1.06
  • TTEC $3.72
  • Resistance Level
  • GOSS $1.26
  • TTEC $4.07
  • Average True Range (ATR)
  • GOSS 0.11
  • TTEC 0.30
  • MACD
  • GOSS 0.03
  • TTEC 0.07
  • Stochastic Oscillator
  • GOSS 67.95
  • TTEC 95.10

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and most of the sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

Share on Social Networks: